Narrow Results Clear All
- Communication Improvement 3
- Education and Training 1
- Error Reporting and Analysis 2
- Human Factors Engineering 4
- Quality Improvement Strategies 2
- Technologic Approaches 1
Search results for "State Governments and Agencies"
- Specific to High-Risk Drugs
- State Governments and Agencies
Journal Article > Study
Defining minimum necessary anticoagulation-related communication at discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition.
Triller D, Myrka A, Gassler J, et al. Jt Comm J Qual Patient Saf. 2018;44:630-640.
Patients prescribed high-risk medications, including anticoagulants, are at increased risk for adverse drug events and may be particularly vulnerable during care transitions. This study describes how a multidisciplinary panel of anticoagulation experts used an iterative consensus-building process to determine what information should be communicated to relevant providers for all patients on anticoagulation undergoing a transition in care.
PA-PSRS Patient Saf Advis. September 2011;8:85-93.
Analyzing reports of medication errors in ambulatory surgery centers, this article discusses common error types and provides suggestions to prevent such events and prioritize improvement efforts.
PA-PSRS Patient Saf Advis. March 2010;7:9-17.
This article analyzed 2685 event reports involving insulin and found that the most common error types were drug omission, wrong-dose, and wrong-drug errors.
PA-PSRS Patient Saf Advis. December 2009;6:109-114.
This article discusses adverse incidents submitted to the Pennsylvania reporting system involving neuromuscular blocking agents and shares strategies to minimize errors with this type of high-alert drug.
PA-PSRS Patient Saf Advis. June 2008;5:53-56.
This article reports on cases of improper IV administration of sterile water, a high-alert substance, for the treatment of hypernatremia and provides risk reduction strategies for this potentially fatal error.
PA-PSRS Patient Saf Advis. September 2007;4:69, 73-77.
Drawing from data submitted to the Patient Safety Authority reporting system, this article documents factors involved in errors related to medication labels and package design. It also provides risk reduction strategies to minimize such errors.
Web Resource > Database/Directory
Tucson, AZ: University of Arizona Center for Education and Research on Therapeutics, Arizona Health Sciences Center; 2010.
This tool identifies drugs that affect the cardiac conduction system in a deleterious fashion.